$1.45 -$0.11 (-7.2%)

02:26 PM EST on 02/25/20

Trovagene Inc (NASDAQ:TROV)

CAPS Rating: 1 out of 5

Current Price $1.45 Mkt Cap $12.1M
Open $1.54 P/E Ratio 0.00
Prev. Close $1.56 Div. (Yield) $0.00 (0.0%)
Daily Range $1.43 - $1.58 Volume 131,386
52-Wk Range $1.18 - $2.35 Avg. Daily Vol. 841,093

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

31 Outperform
8 Underperform
 

All-Star Players

2 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:TROV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (39.62)
Submitted February 04, 2020

This is a tiny company with a drug that actually seems to work. Buying into a company this small and this early in development is probably not sober investing, but taking a small flyer is maybe justifiable. Lots or red flags here, but a… More

TerryHogan (99.97)
Submitted April 26, 2019

These guys haven't made money in at least 4 years, are probably looking at 'going concern' issues in the next 4 unless they do substantial dilution. I only looked at financials - maybe they have a miracle drug ready in the pipeline, but I also see a… More

NASDAQ:TROV VS S&P 500 (SPY)

Fools bullish on NASDAQ:TROV are also bullish on:

Fools bearish on NASDAQ:TROV are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about TROV.

Recs

1
Member Avatar odocoileus (39.62) Submitted: 2/3/2020 8:42:05 PM : Outperform Start Price: $1.68 NASDAQ:TROV Score: -14.75

This is a tiny company with a drug that actually seems to work. Buying into a company this small and this early in development is probably not sober investing, but taking a small flyer is maybe justifiable. Lots or red flags here, but a first-in-class 3rd generation PLK inhibitor that deserves some attention.

Recs

0
Member Avatar JohnnyMac28 (76.49) Submitted: 10/22/2019 10:55:07 AM : Outperform Start Price: $1.98 NASDAQ:TROV Score: -30.31

A crazy pharma flier

Recs

1
Member Avatar DavidLTalbot (< 20) Submitted: 6/12/2015 8:12:43 AM : Outperform Start Price: $80.94 NASDAQ:TROV Score: -148.15

Been in since $5.89, worked out very well so far. Still a deep speculation play based on positive results for cancer mutation monitoring at several of the top cancer specialty hospitals. The key questions are:
1) Commercialization of the cancer mutation monitoring products (they have a few different ones for different cancers) which so far have been proven more effective than biopsies (urine sample versus cutting patient open, big diff) If this works out, this alone could justify a 750m market cap
2) Potentially creating and commercializing broader use urine tests like HPV (in testing) and potentially general cancer screenings for some of the hardest to detect killer cancers like pancreatic or lung cancers. This is further a-field speculation but if this part of the thesis works out it could justify a vastly higher market cap.

Like any speculative biotech play, you're either in for 10x or going to zero so not for the faint of heart.

Leaderboard

Find the members with the highest scoring picks in TROV.

Score Leader

glenn12345

glenn12345 (99.97) Score: +271.56

The Score Leader is the player with the highest score across all their picks in TROV.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Eric2204 99.23 8/20/2012 Underperform 5Y $14.10 -89.50% +122.52% +212.02 0 Comment
GSLogan 85.54 9/20/2013 Underperform 1Y $42.18 -96.49% +84.81% +181.30 0 Comment
WSMOOT19 72.41 1/30/2017 10/9/2019 Underperform 1Y $12.00 -87.67% +38.45% +126.12 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. glenn12345 99.97 5/31/2017 Underperform 5Y $3.90 -62.05% +31.06% +93.12 0 Comment
johnnyrocku 99.90 6/18/2018 Underperform 5Y $5.10 -70.97% +14.67% +85.65 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. OttoBismarck 99.95 11/12/2018 Underperform 5Y $4.57 -67.63% +15.39% +83.02 0 Comment
IdahoInvestor 32.68 8/6/2019 Underperform 5Y $1.67 -11.38% +10.49% +21.87 0 Comment
whatsthepoint 99.99 1/23/2020 Underperform 5Y $1.65 -10.30% -4.48% +5.82 0 Comment
PLAZMASTOX 48.99 1/27/2020 Outperform 3W $1.78 -16.85% -2.12% -14.73 0 Comment
odocoileus 39.62 11/6/2019 Outperform 5Y $1.68 -11.64% +3.11% -14.75 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for TROV.